Tissue renin angiotensin systems

Medical Clinics of North America

Volumn 88, Issue 1, 2004, Pages 19-38

  Re, Richard N ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; BRADYKININ B2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; RENIN;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL TONE; CELL CULTURE; CIRCULATION; DIMERIZATION; HEMODYNAMICS; HUMAN; IMMUNOREGULATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VASOCONSTRICTION;

EID: 0742287703     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(03)00124-X     Document Type: Review

References (121)

1. Re R.N. The renin angiotensin system. Med Clin North Am. 71:1987;877-895.
2. Re R.N. The clinical implication of tissue renin angiotensin systems. Curr Opin Cardiol. 16:2001;317-327.
3. Ruilope L. Improving prognosis in hypertension: exploring the benefits of angiotensin II type I receptor blockade. Blood Press Suppl. 1:2000;31-35.
4. Brenner B.M., Cooper M.E., de Zeeuw D., Keane W.F., Mitch W.E., Parving H.H., et al., RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 345:2001;861-869.
5. Lewis E.J., Hunsicker L.G., Clarke W.R., Berl T., Pohl M.A., Lewis J.B., et al., Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 45:2001;851-860.
6. Lindholm L.H., Ibsen H., Dahlof B., Devereux R.B., Beevers G., de Faire U., et al., LIFE Study Group. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 359:2002;1004-1010.
7. Manley H.J. Role of angiotensin-converting-enzyme inhibition in patients with renal disease. Am J Health Syst Pharm. 57:(suppl 1):2000;S12-S18.
8. Ruggenenti P., Perna A., Gherardi G., Garini G., Zoccali C., Salvadori M., et al. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet. 354:1999;359-364.
9. Holdaas H., Hartmann A., Berg K.J., Lund K., Fauchald P. Renal effects of losartan and amlodipine in hypertensive patients with non-diabetic nephropathy. Nephrol Dial Transplant. 13:1998;3096-3102.
10. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:1991;293-301.
11. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med. 327:1992;669-677.
12. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 342:2000;145-153.
13. Brilla C.G., Reinhard C., Funck R.C., Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation. 102:2000;1388-1393.
14. Schwartzkopff B., Brehm M., Mundhenke M., Strauer B.E. Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease. Hypertension. 36:2000;220-225.
15. Burnier M. Angiotensin II type I receptor blockers. Circulation. 103:2001;904-912.
16. Dzau V.J. Tissue angiotensin and pathology of vascular disease: a unifying hypothesis. Hypertension. 37:2001;1047-1052.
17. Delcayre C., Silvestre J.S., Garnier A., Oubenaissa A., Cailmail S., Tatara E., et al. Cardiac aldosterone production and ventricular remodeling. Kidney Int. 57:2000;1346-1351.
18. Rajagopalan S., Pitt B. Aldosterone as a target in congestive heart failure. Med Clin North Am. 87:2003;441-457.
19. Re R.N. Cellular biology of the renin angiotensin systems. Arch Intern Med. 144:1984;2037-2041.
20. Dzau V.J., Re R. Tissue angiotensin systems in cardiovascular medicine: a paradigm shift? Circulation. 89:1994;493-498.
21. Von Lutterotti N., Catanzaro D., Sealey J.E., Laragh J.H. Renin is not synthesized by cardiac and extra renal vascular tissues: review of experimental evidence. Circulation. 89:1994;458-470.
22. Danser A.H.J., van Kats J.P., Admirall P.J.J., Derkx F.H.M., Lamers J.M.J., Verdouw P.D., et al. Cardiac renin and angiotensins: uptake from plasma versus in situ synthesis. Hypertension. 24:1994;37-48.
23. Re R.N., Fallon J.T., Dzau V.S., Quay S., Haber E. Renin synthesis by cultured arterial smooth muscle cells. Life Sci. 30:1982;99-106.
24. Dzau V.J., Re R.N. Evidence for the existence of renin in the heart. Circulation. 75:(suppl I):1987;I-134-I-136.
25. Dostal D.E., Baker K.M. The cardiac renin-angiotensin system: conceptual, or regulator of cardiac function? Circ Res. 85:1999;643-650.
26. Malhotra R., Sadoshima J., Brosius F.C. III, Izumo S. Mechanical stretch and angiotensin II differentially upregulate the renin-angiotensin system in cardiac myocytes in vitro. Circ Res. 85:1999;137-146.
27. Barlucchi L., Leri A., Dostal D.E., Fiordaliso F., Tada H., Hintze T.H., et al. Canine ventricular myocytes possess a renin-angiotensin system that is up-regulated with heart failure. Circ Res. 88:2001;298-304.
28. Morgan T., Craven C., Ward K. Human spiral artery renin-angiotensin system. Hypertension. 32:1998;683-687.
29. Iwai N., Izumi M., Inagami T., Kinoshita M. Induction of renin in medial smooth muscle cells by balloon injury. Hypertension. 29:1997;1044-1050.
30. Sun Y., Zhang J., Zhang J.Q., Weber K.T. Renin expression at sites of repair in the infarcted rat heart. J Mol Cell Cardiol. 33:2001;995-1003.
31. Lou Y.K., Robinson B.G., Morris B.J. Renin messenger RNA, detected by polymerase chain reaction, can be switched on in rat atrium. J Hypertens. 11:1993;237-243.
32. Lee-Kirsch M.A., Gaudet F., Cardoso M.C., Lindpaintner K. Distinct renin isoforms generated by tissue-specific transcription initiation and alternative splicing. Circ Res. 84:1999;240-246.
33. Clausmeyer S., Sturzebecher R., Peters J. An alternative transcript of the rat renin gene can result in a truncated prorenin that is transported into adrenal mitochondria. Circ Res. 84:1999;337-344.
34. Clausmeyer S., Reinecke A., Farrenkopf R., Unger T., Peters J. Tissue-specific expression of a rat renin transcript lacking the coding sequence for the prefragment and its stimulation by myocardial infarction. Endocrinology. 141:2000;2963-2970.
35. Peters J., Obermuller N., Woyth A., Peters B., Maser-Gluth C., Kranzlin B., et al. Losatan and angiotensin II inhibit aldosterone production in anephric rats via different actions on the intraadrenal renin-angiotensin system. Endocrinology. 140:1999;675-682.
36. Wang Y., Yamaguchi T., Franco-Saenz R., Mulrow P.J. Regulation of renin gene expression in rat adrenal glomerulosa cells. Hypertension. 20:1992;776-781.
37. Cassis L.A., Lynch K.R., Peach M.J. Localization of angiotensin messenger RNA in rat aorta. Circ Res. 62:1988;1259-1262.
38. Sarzani R., Fallo F., Dessi-Fulgheri P., Pistorello M., Lanari A., Paci V.M., et al. Local renin-angiotensin system in human adrenals and aldosteronomas. Hypertension. 19:1992;702-707.
39. Volpe M., Gigante B., Enea I., Porcellini A., Russo R., Lee M.A., et al. Role of tissue renin in the regulation of aldosterone biosynthesis in the adrenal cortex of nephrectomized rats. Circ Res. 81:1997;857-864.
40. Re R.N. The intracrine hypothesis and intracellular peptide hormone action. Bioessays. 25:2003;401-409.
41. Wang J.M., Slembrouck D., Tan J., Arckens L., Leenen F.H., Courtoy P.J., et al. Presence of cellular renin-angiotensin system in chromaffin cells of bovine adrenal medulla. Am J Physiol Heart Circ Physiol. 283:2002;H1811-H1818.
42. Wilkinson-Berka J.L., Kelly D.J., Gilbert R.E. The interaction between the renin-angiotensin system and vascular endothelial growth factor in the pathogenesis of retinal neovascularization in diabetes. J Vasc Res. 38:2001;527-536.
43. Sernia C., Shinkel T.A., Thomas W.G., Lincoln D. Angiotensinogen secretion by single rat pituitary cells: detection by a reverse haemolytic plaque assay and cell identification by immunocytochemistry. Neuroendocrinology. 55:1992;308-316.
44. Vila-Porcile E., Barret A., Corvol P. Secretion of renin-angiotensin system (RAS) components by normal and tumoral lactotropes: a comparative study using reverse hemolytic plaque assay (RHPA). J Histochem Cytochem. 48:2000;1691-1704.
45. Berka J.L., Stubbs A.J., Wang D.Z., DiNicolantonio R., Alcorn D., Campbell D.J., et al. Renin-containing Muller cells of the retina display endocrine features. Invest Ophtalmol Vis Sci. 36:1995;1450-1458.
46. Diet F., Pratt R.E., Berry G.J., Momose N., Gibbons G.H., Dzau V.J. Increased accumulation of tissue ACE in human atherosclerotic coronary disease. Circulation. 94:1996;2756-2767.
47. Morishita R., Gibbons G.H., Ellison K.E., Lee W., Zhang L., Yu H., et al. Evidence for direct local effect of angiotensin in vascular hypertrophy. in vivo gene transfer of angiotensin converting enzyme. J Clin Invest. 94:1994;978-984.
48. Lumbers E. The ovary. Robertson J.I.S., Nicholls M.G. The renin-angiotensin system. 1993;46.1-46.12 Gower Medical Publishing, New York.
49. Lumbers E. Renin uterus and amniotic fluid. Robertson J.I.S., Nicholls M.G. The renin-angiotensin system. 1993;45.1-45.12 Gower Medical Publishing, New York.
50. Li C., Ansari R., Yu Z., Shah D. Definitive molecular evidence of renin-angiotensin system in human uterine decidual cells. Hypertension. 36:2000;159-164.
51. Poulsen K., Jacobson J. Enzymatic reactions of the renin-angiotensin system. Robertson J.I.S., Nicholls M.G. The renin-angiotensin system. 1993;5.1-5.12 Gower Medical Publishing, New York.
52. Urata H., Boehm K.D., Philip A., Kinoshita A., Gabrovsek J., Bumpus F.M., et al. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest. 91:1993;1269-1281.
53. Jutras I., Reudelhuber T.L. Prorenin processing by cathepsin B in vitro and in transfected cells. FEBS Lett. 443:1999;48-52.
54. Shiota N., Okunishi H., Takai S., Mikoshiba I., Sakonjo H., Shibata N., et al. Tranilast suppresses vascular chymase expression and neointima formation in balloon-injured dog carotid artery. Circulation. 99:1999;1084-1090.
55. Snyder R.A., Kaempfer C.E., Wintroub B.U. Chemistry of a human monocyte-derived cell (U937): identification of the angiotensin I-converting activity as leukocyte cathepsin G. Blood. 65:1985;176-182.
56. Hu W.Y., Fukuda N., Satoh C., Jian T., Kubo A., Nakayama M., et al. Phenotypic modulation by fibronectin enhances the angiotensin II-generating system in cultured vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 20:2000;1500-1505.
57. Shenoy U., Cassis L. Characterization of renin activity in brown adipose tissue. Am J Physiol. 272:1997;C989-C999.
58. Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 87:2000;E1-E9.
59. Gorzelniak K., Engeli S., Janke J., Luft F., Sharma A.M. Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension. J Hypertens. 20:2002;965-973.
60. Brosnihan K.B., Li P., Tallant E.A., Ferrario C.M. Angiotensin-(1-7): a novel vasodilator of the coronary circulation. Biol Res. 31:1998;227-234.
61. Chappell M.C., Allred A.J., Ferrario C.M. Pathways of angiotensin (1-7) metabolism in the kidney. Nephrol Dial Transplant. 16:(suppl I):2001;22-26.
62. Brosnihan K.B., Li P., Tallant E.A., Ferrario C.M. Angiotensin-(1-7): a novel vasodilator of the coronary circulation. Biol Res. 31:1998;227-234.
63. Wilkinson-Berka J., Kelly D., Rong P., Campbell D., Skinner S. Characterisation of a thymic renin-angiotensin system in the transgenic m(Ren-2)27 rat. Mol Cell Endocrinol. 194:2002;201.
64. Kitazono T., Padgett R.G., Armstrong M.L., Tompkins P.K., Heistad D.D. Evidence that angiotensin II is present in human monocytes. Circulation. 91:1995;1129-1134.
65. Karlsson C., Lindell K., Ottosson M., Sjostrom L., Carlsson B., Carlsson L.M. Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J Clin Endocrinol Metab. 83:1998;3925-3929.
66. Okamura A., Rakugi H., Ohishi M., Yanagitani Y., Takiuchi S., Moriguchi K., et al. Up-regulation of renin-angiotensin system during differentiation of monocytes to macrophages. J Hypertension. 17:1999;537-545.
67. Iwai N., Inagami T., Ohmichi N., Kinoshita M. Renin is expressed in rat macrophage/monocyte cells. Hypertension. 27:1996;399-403.
68. Pinterova L., Krizanova O., Zorad S. Rat epididymal fat tissue express all components of the renin-angiotensin-system. Gen Physiol Biophys. 19:2000;329-334.
69. Phillips M.I., Speakman E.A., Kimura B. Levels of angiotensin and molecular biology of the tissue renin angiotensin systems. Regul Pept. 43:1993;1-20.
70. Bunnemann B., Fuxe K., Ganten D. The brain renin-angiotensin system: localization and general significance. J Cardiovasc Pharmacol. 19:(suppl 6):1992;S51-S62.
71. Fuchs S., Germain S., Philippe J., Corvol P., Pinet F. Expression of renin in large arteries outside the kidney revealed by human renin promoter/ LacZ transgenic mouse. Am J Pathol. 161:2002;717-725.
72. Mercure C., Ramla D., Garcia R., Thibault G., Deschepper C.F., Reudelhuber T.L. Evidence for intracellular generation of angiotensin II in rat juxtaglomerular cells. FEBS Lett. 422:1998;395-399.
73. De Mello W.C. Influence of intracellular renin on heart cell communication. Hypertension. 25:1995;1172-1177.
74. DeMello W.C. Intracellular angiotensin II regulates the inward calcium current in cardiac myocytes. Hypertension. 32:1998;976-982.
75. De Mello W.C. Cardiac arrhythmias: the possible role of the renin-angiotensin system. J Mol Med. 79:2001;103-108.
76. Peters J., Farrenkopf R., Clausmeyer S., Zimmer J., Kantachuvesiri S., Sharp M.G.F., et al. Functional significance of prorenin internalization in the rat heart. Circ Res. 90:2002;1135-1141.
77. Frustaci A., Kajstura J., Chimenti C., Jakoniuk I., Leri A., Maseri A., et al. Myocardial cell death in human diabetes. Circ Res. 87:2000;1123-1132.
78. Saris J.J., Derkx F.H., Lamers J.M., Saxena P.R., Schalekamp M.A., Danser A.H. Cardiomyocytes bind and activate native prorenin: role of soluble mannose 6-phosphate receptors. Hypertension. 37:2001;710-715.
79. Nguyen G., Delarue F., Burckle C., Bouzhir L., Giller T., Sraer J.-D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 109:2002;1417-1427.
80. Nguyen G., Delarue F., Berrou J., Rondeau E., Sraer J.D. Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int. 50:1996;1897-1903.
81. Nussberger J. Circulating versus tissue angiotensin II. Epstein M., Brunner H.R. Angiotensin II receptor antagonists. 2001;69-78 Hanley & Belfus, Philadelphia.
82. Serneri G.G.N., Boddi M., Coppo M., Chechi T., Zarone N., Poggesi L., et al. Evidence for the existence of a functional cardiac renin-angiotensin system in humans. Circulation. 94:1996;1886-1896.
83. Serneri G.G.N., Boddi M., Cecioni I., Vanni V., Coppo M., Papa L., et al. Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function. Circ Res. 88:2001;961-971.
84. Mizuno Y., Yoshimura M., Yasue H., et al. Aldosterone production is activated in failing ventricle in humans. Circulation. 103:2001;72-77.
85. Yamamoto N., Yasue H., Mizuno Y., Yoshimura M., Fujii H., Nakayama M., et al. Aldosterone is produced from ventricles in patients with essential hypertension. Hypertension. 39:2002;958-962.
86. Ito T., Yoshimura M., Nakamura S., Nakayama M., Shimasaki Y., Harada E., et al. Inhibitory effect of natriuretic peptides on aldosterone synthase gene expression in cultured neonatal rat cardiocytes. Circulation. 107:2003;807-810.
87. Harada E., Yoshimura M., Yasue H., Nakagawa O., Nakagawa M., Harada M., et al. Aldosterone Induces angiotensin-converting enzyme gene expression in cultured neonatal rat cardiocytes. Circulation. 104:2001;137-139.
88. Strawn W.B., Chappell M.C., Dean R.H., Kivlighn S., Ferrario C.M. Inhibition of early atherosclerosis by losartan in monkeys with diet-induced hypercholesterolemia. Circulation. 2000;1586-1593.
89. Fujimoto Y., Sasaki T., Tsuchida A., Chayama K. Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist. FEBS Lett. 495:2001;197-200.
90. Rivera E., Arrieta O., Guevara P., Duarte-Rojo A., Sotelo J. AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma. Br J Cancer. 85:2001;1396-1399.
91. Wulf G.G., Jahns-Streubel G., Nobiling R., Strutz F., Hemmerlein B., Hiddemann W., et al. Renin in acute myeloid leukaemia blasts. Br J Haematol. 100:1998;335-337.
92. Cook J., Chen L., Bhandaru S., Bakris G.L., Re R.N. The use of antisense oligonucleotides to establish autocrine angiotensin growth effects in human neuroblastoma and mesangial cells. Antisense Res Dev. 2:1992;199-210.
93. Cook J.L., Bhandaru S., Giardina J.F., Claycomb W.C., Re R.N. Identification and antisense inhibition of a renin-angiotensin system in transgenic cardiomyocytes. Am J Physiol. 268:1995;H1471-H1482.
94. Chen L., Prakash O., Re R.N. The Interaction of insulin and angiotensin II on the regulation of human neuroblastoma cell growth. Mol Chem Neuropathol. 18:1993;189-196.
95. Chen L., Re R.N., Prakash O., Mondal D. Angiotensin converting enzyme inhibition reduces neuroblastoma cell growth rate. Proc Soc Exp Biol Med. 196:1991;280-283.
96. Taylor G.M., Cook H.T., Sheffield E.A., Hanson C., Peart W.S. Renin in blood vessels in human pulmonary tumors: an immunohistochemical and biochemical study. Am J Pathol. 130:1988;543-551.
97. Delorenzi A., Maldonado H. Memory enhancement by the angiotensinergic system in the crab Chasmagnathus is mediated by endogenous angiotensin II. Neurosci Lett. 266:1999;1-4.
98. Raghavendra V., Chopra K., Kulkarni S.K. Comparative studies on the memory-enhancing actions of captopril and losartan in mice using inhibitory shock avoidance paradigm. Neuropeptides. 35:2001;65-69.
99. Kramar E.A., Armstrong D.L., Ikeda S., Wayner M.J., Harding J.W., Wright J.W. The effects of angiotensin IV analogues on long-term potentiation within the CA1 region of the hippocampus in vitro. Brain Res. 897:2001;114-121.
100. Ricard P., Danilo P. Jr., Cohen I.S., Burkhoff D., Rosen M.R. A role for the renin-angiotensin system in the evolution of cardiac memory. J Cardiovasc Electrophysiol. 10:1999;545-551.
101. Kerins D.M., Hao Q., Vaughan D.E. Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. J Clin Invest. 96:1995;2515-2520.
102. AbdAlla S. Lother H, el Massiery A, Quitterer U. Increased AT(1) receptor heterodimers in preeclampsia medicate enhanced angiotensin II responsiveness. Nat Med. 7:2001;1003-1009.
103. AdbAlla S., Abdel-tawab A.M., Quitterer U. The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem. 276:2001;39721-39726.
104. Chao-Hung W., Shu-Hong L., Weisel R.D., Fedak P.W.M., Dumont A.S., Szmitko P., et al. C-reactive protein up-regulates angiotensin type 1 receptors in vascular smooth muscle. Circulation. 107:2003;1783-1790.
105. Leri A., Liu Y., Li B., Fiordaliso F., Malhortra A., Latini R., et al. Up-regulation of At-1 and At-2 receptors in postinfarcted hypertrophied myocytes and stretch-mediated apoptotic cell death. Am J Pathol. 156:2000;1663-1672.
106. Siragy H.M. AT(1) and AT(2) receptors in the kidney: role in disease and treatment. Am J Kidney Dis. 3:(suppl 1):2000;S4-S9.
107. Fujiyama S., Matsubara H., Nozawa Y., et al. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated receptor transactivation. Circ Res. 88:2001;22-29.
108. Machado R.D., Santos R.A., Andrade S.P. Opposing actions of angiotensins on angiogenesis. Life Sci. 66:2000;67-76.
109. Crackower M.A., Sarao R., Oudit G.Y., Yagil C., Kozieradzki I., Scanga S.E., et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 417:2002;799-802.
110. Morishita R., Gibbons G.H., Tomita N., Zhang L., Kaneda Y., Ogihara T., et al. Antisense oligodeoxynucleotide inhibition of vascular angiotensin-converting enzyme expression attenuates neointimal formation: evidence for tissue angiotensin-converting enzyme function. Arterioscler Thromb Vasc Biol. 20:2000;915-922.
111. Mazzolai L., Pedrazzini T., Nicoud F., Gabbiani G., Brunner H.R., Nussberger J. Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normotensive mice. Hypertension. 35:2000;985-991.
112. Mazzolai L., Nussberger J., Aubert J.F., Brunner D.B., Gabbiani G., Brunner H.R., et al. Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension. 31:1998;1324-1330.
113. Cook J.L., Zhang Z., Re R.N. In vitro evidence for an intracellular site of angiotensin action. Circ Res. 89:2001;1138-1146.
114. Re R.N. Toward a theory of intracrine hormone action. Regul Pept. 106:2002;1-6.
115. Re R.N. The nature of intracrine peptide hormone action. Hypertension. 34:1999;534-538.
116. Re R.N. The origins of intracrine hormone action. Am J Med Sci. 323:2002;43-48.
117. Price D.A., Porter L.E., Gordon M., Fisher N.D., De'Oliveira J.M., Laffel L.M., et al. The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol. 10:1999;2382-2391.
118. Lansang C.M., Price D.A., Laffel L.M.B., Osel S.Y., Fisher N.D.L., Erani D., et al. Renal vascular responses to captopril and to candesartan in patients with type I diabetes mellitus. Kidney Int. 59:2001;1432-1438.
119. Navar L.G., Harrison-Bernard L.M. Intrarenal angiotensin II augmentation in angiotensin II dependent hypertension. Hypertens Res. 23:2000;291-301.
120. Kida T., Ikeda T., Nishimura M., Sugiyama T., Imamura Y., Sotozono C., et al. Renin-angiotensin system in proliferative diabetic retinopathy and its gene expression in cultured human Muller cells. Jpn J Ophthalmol. 47:2003;36-41.
121. Caron A.Z., Arguin G., Guillemette G. Angiotensin IV interacts with a juxtamembrane site on AT(4)/IRAP suggesting an allosteric mechanism of enzyme modulation. Regul Pept. 113:2003;9-15.